Voclosporin denied for failing step therapy by Aetna?

Aetna's specific coverage criteria for voclosporin are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Requires Step Therapy Before Approving Voclosporin

Step therapy — sometimes called "fail-first" — requires a patient to try one or more less-expensive or traditionally preferred treatments before a plan will authorize a newer agent like voclosporin. For lupus nephritis, Aetna's step protocol typically requires documented prior use of conventional immunosuppressive agents. A step-therapy denial means Aetna's records do not show adequate trial of those required steps, or that the documentation submitted was insufficient to demonstrate them.

Step-therapy denials are among the most consistently reversed on appeal because many patients have already completed the required steps — the documentation just needs to be assembled and presented clearly.

## Step-Therapy Override: The Fastest Path

Before filing a full internal appeal, ask your prescriber to submit a step-therapy override request (also called a clinical exception). Most Aetna plans are required by state law or plan terms to grant an exception when: - The required step agent was previously tried and did not produce adequate response. - The required step agent is medically contraindicated or otherwise clinically inappropriate for this patient (per the prescriber's judgment, documented in the chart). - Requiring the step would delay medically necessary care and worsen outcomes.

## Your Formal Appeal Rights

• Internal appeal (ERISA §503 / ACA): File within the deadline on the denial notice, attaching the full treatment history.
• External review (ACA §2719): After an internal denial, you have approximately four months to request binding independent external review. Reviewers apply clinical standards, not just plan-specific step lists.
• State step-therapy protections: Many states have enacted step-therapy reform laws that require plans to recognize prior treatment, limit the number of required steps, and provide expedited exception processes. Check whether your state's law applies to your plan type.

## Documentation to Gather

1. Comprehensive treatment history — a chronological list of every immunosuppressive or conventional LN therapy the patient has tried, with start and stop dates and documented reasons for each change (inadequate efficacy, intolerance, adverse event). 2. Clinical notes corroborating the history — prescriber notes, laboratory results, and specialist correspondence that confirm each treatment trial and its outcome. 3. Prescriber's exception letter — a letter from the treating nephrologist or rheumatologist explaining why voclosporin is necessary now and why the step-therapy sequence has been satisfied or should not apply to this patient. 4. Current disease status — documentation of active lupus nephritis requiring treatment escalation.

## Criteria-Mapping Structure

Obtain Aetna's step-therapy criteria for voclosporin (request from the PA team or provider portal). Map each required step:

| Step Therapy Requirement | Compliance Evidence | |---|---| | Step 1 agent (as listed in policy) | Dates tried, outcome, reason discontinued | | Step 2 agent (if required) | Dates tried, outcome, reason discontinued | | Exception criterion met (if applicable) | Clinical contraindication or inadequate-response documentation |

A complete, date-anchored treatment history attached to the appeal letter resolves the majority of step-therapy denials.